Principal Financial Group
CORT icon

Principal Financial Group’s Corcept Therapeutics CORT Stock Holding History

Principal Financial Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40M Buy
459,742
+4,494
+1% +$271K 0.02% 611
2026
Q1 		$18.4M Buy
455,248
+11,156
+3% +$417K 0.01% 977
2025
Q4 		$15.5M Sell
444,092
-77,408
-15% -$6.08M 0.01% 1048
2025
Q3 		$43.3M Sell
521,500
-13,949
-3% -$1.01M 0.02% 515
2025
Q2 		$39.3M Buy
535,449
+4,989
+0.9% +$362K 0.02% 532
2025
Q1 		$60.6M Buy
530,460
+13,128
+3% +$799K 0.03% 403
2024
Q4 		$26.1M Buy
517,332
+21,674
+4% +$1.14M 0.01% 710
2024
Q3 		$22.9M Sell
495,658
-20,770
-4% -$738K 0.01% 766
2024
Q2 		$16.8M Sell
516,428
-9,710
-2% -$266K 0.01% 970
2024
Q1 		$13.3M Buy
526,138
+26,452
+5% +$625K 0.01% 1160
2023
Q4 		$16.2M Sell
499,686
-4,807
-1% -$132K 0.01% 1027
2023
Q3 		$13.7M Sell
504,493
-23,308
-4% -$675K 0.01% 1037
2023
Q2 		$11.7M Sell
527,801
-58,458
-10% -$1.35M 0.01% 1173
2023
Q1 		$12.7M Sell
586,259
-14,592
-2% -$320K 0.01% 1131
2022
Q4 		$12.2M Sell
600,851
-10,864
-2% -$272K 0.01% 1128
2022
Q3 		$15.7M Sell
611,715
-45,952
-7% -$1.23M 0.01% 927
2022
Q2 		$15.6M Buy
657,667
+12,593
+2% +$274K 0.01% 1006
2022
Q1 		$14.5M Sell
645,074
-3,635
-0.6% -$77.3K 0.01% 1141
2021
Q4 		$12.8M Sell
648,709
-82,815
-11% -$1.68M 0.01% 1256
2021
Q3 		$14.4M Sell
731,524
-9,993
-1% -$209K 0.01% 1188
2021
Q2 		$16.3M Sell
741,517
-4,899
-0.7% -$109K 0.01% 1140
2021
Q1 		$17.8M Buy
746,416
+2,400
+0.3% +$64.1K 0.01% 1017
2020
Q4 		$19.5M Sell
744,016
-14,383
-2% -$303K 0.01% 788
2020
Q3 		$13.2M Sell
758,399
-27,816
-4% -$443K 0.01% 900
2020
Q2 		$13.2M Sell
786,215
-11,038
-1% -$155K 0.01% 882
2020
Q1 		$9.48M Sell
797,253
-31,123
-4% -$385K 0.01% 938
2019
Q4 		$10M Buy
828,376
+3,142
+0.4% +$43.7K 0.01% 1248
2019
Q3 		$11.7M Sell
825,234
-13,048
-2% -$160K 0.01% 1124
2019
Q2 		$9.35M Sell
838,282
-62,336
-7% -$695K 0.01% 1257
2019
Q1 		$10.6M Sell
900,618
-14,475
-2% -$180K 0.01% 1204
2018
Q4 		$12.2M Sell
915,093
-2,976
-0.3% -$39.3K 0.01% 1046
2018
Q3 		$12.9M Buy
918,069
+111,430
+14% +$1.56M 0.01% 1175
2018
Q2 		$12.7M Buy
806,639
+25,939
+3% +$451K 0.01% 1150
2018
Q1 		$12.8M Buy
780,700
+22,684
+3% +$420K 0.01% 1103
2017
Q4 		$13.7M Buy
758,016
+719,324
+1,859% +$13M 0.01% 1070
2017
Q3 		$747K Sell
38,692
-5,599
-13% -$83.5K ﹤0.01% 1870
2017
Q2 		$523K Buy
44,291
+29,451
+198% +$320K ﹤0.01% 1943
2017
Q1 		$163K Hold
14,840
– – ﹤0.01% 2105
2016
Q4 		$108K Buy
14,840
+393
+3% +$3.08K ﹤0.01% 2148
2016
Q3 		$94K Sell
14,447
-431
-3% -$2.51K ﹤0.01% 2104
2016
Q2 		$81K Buy
14,878
+2,218
+18% +$11.5K ﹤0.01% 2105
2016
Q1 		$59K Buy
12,660
+2,188
+21% +$8.52K ﹤0.01% 2115
2015
Q4 		$52K Hold
10,472
– – ﹤0.01% 2144
2015
Q3 		$39K Sell
10,472
-6,566
-39% -$33.3K ﹤0.01% 2151
2015
Q2 		$102K Buy
+17,038
New +$104K ﹤0.01% 2128
2015
Q1 		– Sell
-15,521
Closed -$47K – 2166
2014
Q4 		$47K Sell
15,521
-2,727
-15% -$8.31K ﹤0.01% 2155
2014
Q3 		$49K Hold
18,248
– – ﹤0.01% 2185
2014
Q2 		$51K Sell
18,248
-8,954
-33% -$26.4K ﹤0.01% 2234
2014
Q1 		$119K Buy
+27,202
New +$95.1K ﹤0.01% 2213
2013
Q4 		– Sell
-25,992
Closed -$41K – 2281
2013
Q3 		$41K Buy
+25,992
New +$45.8K ﹤0.01% 2255

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Principal Financial Group's CORT Position: Q2 2026 in Review

Principal Financial Group increased its Corcept Therapeutics (CORT) stake by 0.99% in Q2 2026, buying an estimated $271K and bringing the position to 459,742 shares worth $40M. The position accounts for 0.02% of the portfolio, ranked #611.

Principal Financial Group first reported a position in CORT in Q3 2013 and has held it in 50 quarters since. The position peaked at $60.6M in Q1 2025. 188 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Principal Financial Group held 459,742 shares of Corcept Therapeutics worth $40M as of Q2 2026.
  • Principal Financial Group bought 4,494 Corcept Therapeutics shares in Q2 2026, an estimated $271K.
  • Corcept Therapeutics made up 0.02% of Principal Financial Group's portfolio in Q2 2026, its #611 holding.
  • Principal Financial Group first reported a position in Corcept Therapeutics in Q3 2013 and has held it in 50 quarters since.
  • Principal Financial Group's Corcept Therapeutics position peaked at $60.6M in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.